Qbic has participated in a $32.8m funding round for EyeD, consisting of $9.4m in equity and another $23.4m in debt financing and government grants.

EyeD, a Belgium-based developer of an implant to treat glaucoma that was spun out of the University Hospital of Liège (CHU Liège), has raised a total of €28m ($32.8m) from investors including multi-university venture fund Qbic. Qbic participated in an $9.4m equity tranche together with Fund+ and assorted private investors. The remaining $23.4m came in…

The rest of this content is only accessible to Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.